On our screens:Cheap stocks by free cash flow yield
The financials
Globus Medical, Inc. by the numbers
Globus Medical, Inc. (GMED) reported revenue of $760M in Q1 2026 (quarter ended Mar 31, 2026), up 27% from the same quarter a year earlier. That came with a gross margin of 69% and net income of $124M (16% of revenue). For the full year FY2025, revenue was $2.94B (+17% year on year) and net income $538M. Its largest product in Jun 2026 was Musculoskeletal Solutions at $764M, 97% of the disclosed total, well ahead of Enabling Technologies at 3.3%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $760M | $598M | +27% |
| Gross profit | $526M | $403M | +31% |
| Operating income | $150M | $97M | +55% |
| Net income | $124M | $75M | +65% |
| Diluted EPS | $0.90 | $0.54 | +67% |
| Product | Revenue | Share |
|---|---|---|
| Musculoskeletal Solutions | $764M | 97% |
| Enabling Technologies | $26M | 3.3% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $789.6M (+3.9%)
Segment Latestquarter on quarteryear on year
- Musculoskeletal Solutions$763.5M$763.5MQoQ +4.2%year on year +7.5%+4.2%+7.5%
- Enabling Technologies$26.1M$26.1MQoQ -3.0%year on year -26%-3.0%-26%
Medical Devices
Ranks #1 of 29 by Smart Score